SCHEMBL30901985

SCHEMBL30901985

Cc1ccc(C=O)cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
UNG P13051 1/20 0.46
PTPN1 P18031 4/20 0.44
PTPN2 P17706 2/20 0.44
PTPN6 P29350 2/20 0.44
PTGS2 P35354 3/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP2A6 P11509 1/20 0.41
NPC1 O15118 1/20 0.41
CYP2C9 P11712 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MCL1 Q07820 1/20 0.41
HNF4A P41235 1/20 0.41
CASR P41180 1/20 0.40
LCK P06239 1/20 0.40
TRIM24 O15164 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
ALDH1A3 P47895 1/20 0.40
AOX1 Q06278 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10893340 1.00 ALDH1A1 (0.47) ALDH1A1UNGPTPN1PTPN2PTPN6
SCHEMBL102841 0.84 ALDH1A1 (0.52) ALDH1A1UNGPTPN1PTPN2PTPN6
SCHEMBL16464006 0.84 KDM4E (0.42) ALDH1A1UNGPTGS2RAB9AKDM4E
SCHEMBL15650835 0.82 TDP1 (0.43) ALDH1A1PTGS2RAB9AKDM4ECYP2A6
SCHEMBL17402635 0.82 MCL1 (0.44) ALDH1A1PTPN1PTPN2PTPN6PTGS2
SCHEMBL12763630 0.81 MEN1 (0.49) ALDH1A1PTGS2RAB9ACYP2A6NPC1
SCHEMBL4613992 0.81 ALDH1A1 (0.52) ALDH1A1UNGPTPN1PTPN2PTPN6
SCHEMBL30589393 0.81 ALDH1A1 (0.52) ALDH1A1UNGPTPN1PTPN2PTPN6
SCHEMBL11533704 0.79 CYP2A6 (0.38) ALDH1A1PTGS2RAB9AKDM4ECYP2A6
SCHEMBL3509685 0.79 ALDH1A1 (0.55) ALDH1A1PTGS2RAB9AKDM4ECYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024107783-A2 NOVEL MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS ENANTA PHARMACEUTICALS, INC. (US) 2024-05-23 WO disclosed